Immunic Inc

Market Cap

$206M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$12.77+$6.94 (+119.04%)

Jun 5, 2026

52W High $15.1352W Low $5.10

Company Details

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, ...

CEO

—

IPO Date

Apr 17, 2014

Website

imux.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$104M

EPS (Diluted)

Free Cash Flow

-$81M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 6, 2026

PENDING

Q1 2026

May 13, 2026

FY 2025

Feb 26, 2026

Q4 2025

Feb 26, 2026

$0-100.0%

Q3 2025

Nov 13, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee